Investor News


March 31, 2017
Not intended for U.S. and UK Media - American Association for Cancer Research (AACR) 108th Annual Meeting:

Phase II Copanlisib Data Show Durable Tumor Response in Indolent Non-Hodgkin's Lymphoma

more


March 22, 2017
Not intended for U.S. and UK Media - American Association for Cancer Research (AACR) 108th Annual Meeting:

Bayer to Showcase Data on Growing Oncology Pipeline at AACR 2017

more


News Overview

 

New Investors

Your are interested in Bayer as a new investor? On this page you find helpful links to information on the company and our shares, latest financial reports and key figures, news and events, corporate governance, sustainability and services for investors.

New Investors

Highlights


Publication of First Quarter 2017 results

Publication of First Quarter 2017 results
  • Transcript (as soon as it becomes available)
     

Q1 2017 Consensus Estimates

Q1 2017 Consensus Estimates

The company is covered by various German and international financial analysts.

The analyst consensus for Q1 2017 is given here.


EXTEL 2017 Survey

EXTEL 2017 Survey

The Extel 2017 Survey runs from March 22 to April 28, 2017. Both buyside and sellside will give their views on the IR performance of quoted companies and individual IR professionals.

If you believe that Bayer deserves your vote, we would really appreciate your consideration.
 

To the survey


Meet Management - London

Meet Management - London

FY/Q4 2016 All in One Package for Investors and Analysts

FY/Q4 2016 All in One Package for Investors and Analysts

Service for Investors and Analysts:
Download all documents on our Full Year and Fourth Quarter 2016 results in one ZIP file:
 
Download (ZIP, 13 MB) collect


Investor Conference Call: Bayer to Acquire Monsanto

Investor Conference Call: Bayer to Acquire Monsanto

Media conference call

Last updated: April 18, 2017 Copyright © Bayer AG